Episode 220: 220. Semaglutide at 1yr Gives Small Improvement in Questionnaire for those with HFpEF

Kansas City Cardiomyopathy Questionnaire clinical summary score was improved by 7.8 in those individuals with HFpEF that took semaglutide for one year compared to those that took placebo. This is a small difference on a validated score and would cost 16-20K per year. more research is needed.

https://www.nejm.org/doi/full/10.1056/NEJMoa2306963